Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 98

Sort by

Sort Order Select

Journal Articles

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 rearrangements in Anaplastic Large Cell Lymphoma

Aishwarya Ravindran, MBBS, Andrew L. Feldman, MD, Rhett P. Ketterling, MD, Surendra Dasari, PhD, Karen Rech, MD, Ellen D. McPhail, MD, Paul J Kurtin, MD, Min Shi, MDPhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134547

Published: 2020

Journal Articles

The Prognostic Significance of Acquired 1q22 Gain in Multiple Myeloma

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-139093

Published: 2020

Journal Articles

Clinical Value of Next Generation Sequencing in the Detection of Recurring Structural Rearrangements and Copy Number Abnormalities in Acute Myeloid Leukemia

Beth A Pitel, MS, Neeraj Sharma, PhD, Cinthya Zepeda-Mendoza, PhD, James B Smadbeck, PhD, Kathryn E. Pearce, MS, Stephanie A. Smoley, BA, Joselle Cook, MBBS, George Vasmatzis, PhD, Zohar Sachs, MD PhD, David S. Viswanatha, MD, Robert Jenkins, MD PhD, Xinjie Xu, PhD, Sheng Xiao, MD, Nicole Hoppman, PhD, Rhett P. Ketterling, MD, Jess Peterson, MD, Patricia Greipp, DO, Linda B Baughn, PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-139691

Published: 2020

Journal Articles

Heterogeneity of MYC Abnormalities in Multiple Myeloma

Neeraj Sharma, PhD, James B Smadbeck, PhD, Nadine Abdallah, MD, Kathryn E. Pearce, MS, Yan Asmann, PhD, Jess Peterson, MD, Rhett P. Ketterling, MD, Patricia Greipp, DO, P. Leif Bergsagel, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD, Linda B Baughn, PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-140844

Published: 2020

Journal Articles

Differentiating between Hyperdiploidy and Pseudo-Hyperdiploidy in B-Lymphoblastic Leukemia Utilizing Low-Coverage Mate-Pair Sequencing

James B Smadbeck, Beth A Pitel, MA, Kathryn E. Pearce, Sarah H Johnson, MS, Nicole Hoppman, Rhett P. Ketterling, MD, Patricia Griepp, MD, Linda B Baughn, PhD, George Vasmatzis, PhD, Jess Peterson, MD

Blood (2019) 134 (Supplement_1): 5212.

https://doi.org/10.1182/blood-2019-122440

Published: 2019

Journal Articles

Recurrent Chromosomal Abnormalities in Tumoral Lesions of Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Large-Scale Fluorescent in-Situ Hybridization Study on Tissue Biopsy Sections

Pedro Horna, MD, Kathryn E. Pearce, Rhett P. Ketterling, MD, Jess Peterson, MD

Blood (2019) 134 (Supplement_1): 4282.

https://doi.org/10.1182/blood-2019-129116

Published: 2019

Journal Articles

A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH

Blood (2019) 134 (Supplement_1): 1800.

https://doi.org/10.1182/blood-2019-130639

Published: 2019

Journal Articles

Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma

Blood (2019) 134 (Supplement_1): 4396.

https://doi.org/10.1182/blood-2019-122291

Published: 2019

Journal Articles

MIPSS70: Mutation-Enhanced Prognostic System for Transplant Age Patients with Primary Myelofibrosis

Alessandro M. Vannucchi, Paola Guglielmelli, MD PhD, Terra L. Lasho, PhD, Giada Rotunno, MSc, PhD, Carmela Mannarelli, MSc, PhD, Annalisa Pacilli, PhD, Animesh Pardanani, MBBS PhD, Elisa Rumi, MD, Vittorio Rosti, MD, Curtis A. Hanson, MD, Francesco Mannelli, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Alessandro Rambaldi, MD Prof, Francesco Passamonti, MD, Giovanni Barosi, MD, Tiziano Barbui, MD, Ayalew Tefferi, MD

Blood (2017) 130 (Supplement 1): 200.

https://doi.org/10.1182/blood.V130.Suppl_1.200.200

Published: 2017

Journal Articles

Extramedullary Manifestations in World Health Organization-Defined Chronic Myelomonocytic Leukemia: Clinical, Molecular and Prognostic Correlates

Katherine Hoversten, MD, Rangit Vallapureddy, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Rhett P. Ketterling, MD, Curtis A. Hanson, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD, Mrinal M. Patnaik, MDMBBS

Blood (2017) 130 (Supplement 1): 4272.

https://doi.org/10.1182/blood.V130.Suppl_1.4272.4272

Published: 2017

Journal Articles

The Anatomy of Recurrent Thrombosis and Its Risk Factors in Myeloproliferative Neoplasms

Silvia Betti, MD, Daniela Barraco, MD, Mythri Mudireddy, MBBS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2017) 130 (Supplement 1): 4190.

https://doi.org/10.1182/blood.V130.Suppl_1.4190.4190

Published: 2017

Journal Articles

Clinical Significance of Plasma Cell Tetrasomy in Multiple Myeloma

Blood (2017) 130 (Supplement 1): 4402.

https://doi.org/10.1182/blood.V130.Suppl_1.4402.4402

Published: 2017

Journal Articles

Revised DIPSS-Plus: A Composite Clinical, Cytogenetic and Molecular Prognostic System for Primary Myelofibrosis

Ayalew Tefferi, MD, Paola Guglielmelli, MD PhD, Terra L. Lasho, PhD, Francesca Gesullo, MSc, Christy Finke, BS, Francesco Mannelli, Animesh Pardanani, MBBS, PhD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Alessandro M. Vannucchi

Blood (2017) 130 (Supplement 1): 4192.

https://doi.org/10.1182/blood.V130.Suppl_1.4192.4192

Published: 2017

Journal Articles

Molecular Epidemiology of Acute Myeloid Leukemia (AML): Novel Association of Clinical Epidemiologic Exposures with Unique Mutation Groups on Exome Sequencing of Leukemia DNA in the Mayo Clinic AML Epidemiology Cohort

James M. Foran, MD, Michael Heckman, MS, Rhett P. Ketterling, MD, Lisa Sproat, MD MSW, Liuyan Jennifer Jiang, MD, Bruce Eckloff, PhD, Nancy Diehl, Laura E. Finn, MD, Keith Robertson, PhD, Raoul Tibes, MD PhD, James R. Cerhan, MD PhD, Yan W Asmann, PhD

Blood (2017) 130 (Supplement 1): 570.

https://doi.org/10.1182/blood.V130.Suppl_1.570.570

Published: 2017

Journal Articles

Whole-Genome Mate Pair Sequencing Transforms Cytogenetic Analysis of Hematologic Malignancies: Development of a Targeted Panel to Detect Diagnostic/Prognostic Chromosomal Rearrangements and Copy Number Changes in AML

Umut Aypar, PhD, George Vasmatzis, PhD, Sarah K Johnson, PhD, James Smadbeck, PhD, Stephanie A. Smoley, BA, Hutton Kearney, PhD, William Sukov, MD, Rhett P. Ketterling, MD, Katherine Geiersbach, MD, Daniel L. Van Dyke, PhD, Robert Jenkins, MD PhD, Patricia Greipp, DO, Erik Thorland, PhD, Nicole Hoppman, PhD, Linda B Baughn, PhD

Blood (2017) 130 (Supplement 1): 1387.

https://doi.org/10.1182/blood.V130.Suppl_1.1387.1387

Published: 2017

Journal Articles

Phenotypic and Prognostic Relevance of the Who Diagnostic Distinction between Polycythemia Vera and JAK2 -Mutated Essential Thrombocythemia: Combined Analysis of 785 Informative Cases

Silvia Betti, MD, Daniela Barraco, MD, Mythri Mudireddy, MBBS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh D. Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2017) 130 (Supplement 1): 1645.

https://doi.org/10.1182/blood.V130.Suppl_1.1645.1645

Published: 2017

Journal Articles

Targeted Sequencing of Paired Samples in Patients Evolving from Chronic to Blast Phase Myelofibrosis with Parallel Cytogenetic Information

Terra L. Lasho, PhD, Mythri Mudireddy, MBBS, Christy Finke, BS, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Animesh Pardanani, MBBS PhD, Ayalew Tefferi, MD

Blood (2017) 130 (Supplement 1): 1647.

https://doi.org/10.1182/blood.V130.Suppl_1.1647.1647

Published: 2017

Journal Articles

Substratification of Patients with Newly Diagnosed Standard-Risk Multiple Myeloma

Moritz Binder, MDMPH, S. Vincent Rajkumar, MD, Rhett P. Ketterling, MD, Angela Dispenzieri, MD, Martha Q. Lacy, MD, Morie A. Gertz, MD, Francis K Buadi, MD, Suzanne R. Hayman, MD, Yi L. Hwa, DNP, Steven R. Zeldenrust, MD PhD, John A Lust, MD PhD, Stephen J. Russell, MD PhD, Nelson Leung, MD, Prashant Kapoor, MD, Ronald S. Go, MD, Wilson I Gonsalves, MD, Robert A. Kyle, MD, Shaji K. Kumar, MD

Blood (2017) 130 (Supplement 1): 1789.

https://doi.org/10.1182/blood.V130.Suppl_1.1789.1789

Published: 2017

Journal Articles

Whole-Genome Mate Pair Sequencing Reflex Test to Characterize Chromosome Rearrangements in Hematologic Neoplasia

Blood (2017) 130 (Supplement 1): 5115.

https://doi.org/10.1182/blood.V130.Suppl_1.5115.5115

Published: 2017

Journal Articles

Targeted Deep Sequencing in Blast Phase Myeloproliferative Neoplasms

Ayalew Tefferi, MD, Terra L. Lasho, PhD, Mythri Mudireddy, MBBS, Christy Finke, BS, Kebede H. Begna, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Animesh Pardanani, MBBS PhD

Blood (2017) 130 (Supplement 1): 4193.

https://doi.org/10.1182/blood.V130.Suppl_1.4193.4193

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 rearrangements in Anaplastic Large Cell Lymphoma

The Prognostic Significance of Acquired 1q22 Gain in Multiple Myeloma

Clinical Value of Next Generation Sequencing in the Detection of Recurring Structural Rearrangements and Copy Number Abnormalities in Acute Myeloid Leukemia

Heterogeneity of MYC Abnormalities in Multiple Myeloma

Differentiating between Hyperdiploidy and Pseudo-Hyperdiploidy in B-Lymphoblastic Leukemia Utilizing Low-Coverage Mate-Pair Sequencing

Recurrent Chromosomal Abnormalities in Tumoral Lesions of Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Large-Scale Fluorescent in-Situ Hybridization Study on Tissue Biopsy Sections

A Novel Approach to Risk Stratification in Multiple Myeloma Using ISS Stage and FISH

Metaphase Cytogenetics for Risk Stratification in Newly Diagnosed Multiple Myeloma

MIPSS70: Mutation-Enhanced Prognostic System for Transplant Age Patients with Primary Myelofibrosis

Extramedullary Manifestations in World Health Organization-Defined Chronic Myelomonocytic Leukemia: Clinical, Molecular and Prognostic Correlates

The Anatomy of Recurrent Thrombosis and Its Risk Factors in Myeloproliferative Neoplasms

Clinical Significance of Plasma Cell Tetrasomy in Multiple Myeloma

Revised DIPSS-Plus: A Composite Clinical, Cytogenetic and Molecular Prognostic System for Primary Myelofibrosis

Molecular Epidemiology of Acute Myeloid Leukemia (AML): Novel Association of Clinical Epidemiologic Exposures with Unique Mutation Groups on Exome Sequencing of Leukemia DNA in the Mayo Clinic AML Epidemiology Cohort

Whole-Genome Mate Pair Sequencing Transforms Cytogenetic Analysis of Hematologic Malignancies: Development of a Targeted Panel to Detect Diagnostic/Prognostic Chromosomal Rearrangements and Copy Number Changes in AML

Phenotypic and Prognostic Relevance of the Who Diagnostic Distinction between Polycythemia Vera and JAK2 -Mutated Essential Thrombocythemia: Combined Analysis of 785 Informative Cases

Targeted Sequencing of Paired Samples in Patients Evolving from Chronic to Blast Phase Myelofibrosis with Parallel Cytogenetic Information

Substratification of Patients with Newly Diagnosed Standard-Risk Multiple Myeloma

Whole-Genome Mate Pair Sequencing Reflex Test to Characterize Chromosome Rearrangements in Hematologic Neoplasia

Targeted Deep Sequencing in Blast Phase Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only